People of Biomedial MR

Prof. dr. ir. Tom Scheenen

I am a Professor of Medical Imaging at the Radboudumc and lead the Biomedical Magnetic Resonance (BioMR) group. My work sits at the interface of MR physics, engineering, and clinical applications. I lead the development and application of new MRI and MR spectroscopy methods, ranging from 3T to ultra-high-field MR systems (preclinical and clinical), to extract meaningful biological information non-invasively, with a focus on robustness, quantification, and clinical usability.

A central theme in my research is translating technical innovation into practice. I work on challenges such as motion in abdominal imaging, quantitative MRI, (X-nuclei) spectroscopy, and molecular imaging approaches like iron oxide nanoparticle (USPIO)-enhanced MRI for lymph node staging. Much of this work is driven by clinical questions in oncology, particularly prostate cancer, where improved imaging can directly influence patient management.

I operate in close collaboration with clinicians, physicists, engineers, and industry partners, and I am actively involved in international consortia. These collaborations are essential for bridging the gap between method development and implementation in the clinic. I enjoy working in multidisciplinary teams and mentoring researchers across different stages of their careers.

Within Radboudumc, I contribute to the strategic development of medical imaging research, helping to shape a program that connects fundamental innovation to clinical impact. More broadly, I aim to position MRI as a key modality in precision medicine, providing non-invasive, sensitive, and scalable biomarkers that support diagnosis, treatment planning, and therapy monitoring across a range of diseases.